» Articles » PMID: 37197416

AGR2: a Secreted Protein Worthy of Attention in Diagnosis and Treatment of Breast Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 May 17
PMID 37197416
Authors
Affiliations
Soon will be listed here.
Abstract

AGR2 is a secreted protein widely existing in breast. In precancerous lesions, primary tumors and metastatic tumors, the expression of AGR2 is increased, which has aroused our interest. This review introduces the gene and protein structure of AGR2. Its endoplasmic reticulum retention sequence, protein disulfide isomerase active site and multiple protein binding sequences endow AGR2 with diverse functions inside and outside breast cancer cells. This review also enumerates the role of AGR2 in the progress and prognosis of breast cancer, and emphasizes that AGR2 can be a promising biomarker and a target for immunotherapy of breast cancer, providing new ideas for early diagnosis and treatment of breast cancer.

Citing Articles

A High-Affinity Monoclonal Antibody Against the Pancreatic Ductal Adenocarcinoma Target, Anterior Gradient-2 (AGR2/PDIA17).

Robinson R, Reyes L, Christopher B, Duncan R, Burge R, Siegel J Antibodies (Basel). 2024; 13(4).

PMID: 39727484 PMC: 11672854. DOI: 10.3390/antib13040101.


AGR2 knockdown induces ER stress and mitochondria fission to facilitate pancreatic cancer cell death.

Salu P, Tuvin D, Reindl K Biochim Biophys Acta Mol Cell Res. 2024; 1872(1):119854.

PMID: 39353469 PMC: 11608140. DOI: 10.1016/j.bbamcr.2024.119854.


AGR2: The Covert Driver and New Dawn of Hepatobiliary and Pancreatic Cancer Treatment.

Qu S, Jia W, Nie Y, Shi W, Chen C, Zhao Z Biomolecules. 2024; 14(7).

PMID: 39062458 PMC: 11275012. DOI: 10.3390/biom14070743.


AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells.

Yuan S, Wu C, Wang Y, Chan X, Chu H, Yang Y Cell Mol Biol Lett. 2024; 29(1):84.

PMID: 38822246 PMC: 11140979. DOI: 10.1186/s11658-024-00601-w.


Prostate cancer research: tools, cell types, and molecular targets.

Liu A Front Oncol. 2024; 14:1321694.

PMID: 38595814 PMC: 11002103. DOI: 10.3389/fonc.2024.1321694.


References
1.
Ondrouskova E, Sommerova L, Nenutil R, Coufal O, Bouchal P, Vojtesek B . AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients. Exp Mol Pathol. 2017; 102(2):280-283. DOI: 10.1016/j.yexmp.2017.02.016. View

2.
Hrstka R, Nenutil R, Fourtouna A, Maslon M, Naughton C, Langdon S . The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. Oncogene. 2010; 29(34):4838-47. DOI: 10.1038/onc.2010.228. View

3.
Salmans M, Zhao F, Andersen B . The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res. 2013; 15(2):204. PMC: 3672732. DOI: 10.1186/bcr3408. View

4.
Zhang H, Chi J, Hu J, Ji T, Luo Z, Zhou C . Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer. Cancer Lett. 2021; 518:180-195. DOI: 10.1016/j.canlet.2021.06.025. View

5.
Zweitzig D, Smirnov D, Connelly M, Terstappen L, OHara S, Moran E . Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol Cell Biochem. 2007; 306(1-2):255-60. DOI: 10.1007/s11010-007-9562-y. View